Maroua Benlemlih*, Sara Abdou, Noureddine Abdelati, Sanae El Mejjaoui, Tayeb Kebdani, Khalid Hassouni, Hanane EL kacemi and Noureddine Benjaafar
Conventional radiation therapy has been progressively replaced by Fractionated Stereotactic Radiotherapy (FSRT) and single fraction radiosurgery for dealing with benign intracranial lesions. Treatment options for these tumors include surgical resection, fractionated External Beam Radiation Therapy (EBRT), Stereotactic Radiosurgery (SRS), and/or Stereotactic Body Radiation Therapy (SBRT). Purpose of our study is to investigate the safety and efficacy of SBRT in a series of two patients with benign intracranial tumors treated at our radiotherapy department this last year. The first case is a meningioma and the second a tympanic paraganglioma.
